Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma

Zhen Liu, Xiaobin Long, Cheng Chao

  • 1Department of Pathology, Guangzhou Medical University, Guangzhou 510182, China. yajie.zhang@163.com.

BMC Cancer
|April 23, 2014
PubMed
Abstract

Insights

Overexpressed Cyclin-Dependent Kinase 4 (CDK4) promotes nasopharyngeal carcinoma (NPC) by suppressing let-7c microRNA and driving cell proliferation. Targeting CDK4 may offer a therapeutic strategy for NPC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cyclin-Dependent Kinase 4 (CDK4) is crucial for cell cycle progression.
  • The precise role of CDK4 in nasopharyngeal carcinoma (NPC) development remains incompletely understood.

Purpose of the Study:

  • To investigate the molecular mechanisms by which CDK4 contributes to nasopharyngeal carcinogenesis.
  • To evaluate CDK4 as a prognostic biomarker in NPC.

Main Methods:

  • Utilized lentiviral-vector mediated shRNA to suppress CDK4 expression in NPC cells.
  • Analyzed CDK4 protein expression in NPC tissues and normal nasopharyngeal tissues via immunohistochemistry.
  • Assessed cell growth, cell cycle progression, and miRNA expression changes following CDK4 knockdown.
  • Correlated CDK4 expression with patient survival using Kaplan-Meier analysis.

Main Results:

  • CDK4 knockdown significantly inhibited NPC cell growth and cell cycle progression.
  • Suppression of CDK4 led to decreased expression of CCND1, CDK6, and E2F1, and increased p21 expression.
  • Reduced CDK4 expression upregulated let-7c, a tumor-suppressive microRNA, which was downregulated in NPC tissues.
  • Overexpressed CDK4 in NPC tissues correlated with unfavorable prognosis, though not statistically significant (p=0.087).

Conclusions:

  • Overexpressed CDK4 acts as an unfavorable prognostic factor in NPC.
  • CDK4 suppresses tumor-suppressive let-7c via p21/CCND1/CDK6/E2F1 signaling.
  • CDK4 inhibition disrupts NPC cell proliferation through a p15/p16/CDK4/E2F1 feedback loop.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

2.5K